STAT Plus: Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case
The European Commission is in advanced talks with Johnson & Johnson to reserve or buy up-front doses of its Covid-19 vaccine under development.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall,
